Epigenetics in hepatocellular carcinoma

Area of Science:

• Hepatobiliary cancers
• Molecular oncology
• Epigenetics

Background:

• Hepatocellular carcinoma (HCC) is a prevalent and lethal primary liver cancer.
• Genetic and epigenetic alterations are hallmarks of HCC development and progression.
• Epigenetic modifications, including DNA methylation and histone alterations, drive HCC metastasis.

Purpose of the Study:

• To summarize epigenetic modifications implicated in HCC progression.
• To highlight potential epigenetic biomarkers for HCC diagnosis.
• To discuss the role of epigenetics in HCC drug development.

Main Methods:

• Literature review of epigenetic mechanisms in HCC.
• Analysis of studies on DNA methylation, histone modifications, and noncoding RNAs in HCC.
• Synthesis of findings on the clinical relevance of epigenetic alterations.

Main Results:

• Epigenetic aberrations are integral to HCC pathogenesis and metastasis.
• Reversible epigenetic changes offer promising avenues for biomarker discovery.
• Specific epigenetic modifications correlate with HCC progression and therapeutic response.

Conclusions:

• A comprehensive understanding of HCC epigenetics is crucial for clinical advancement.
• Epigenetic biomarkers can improve diagnostic accuracy and treatment prediction in HCC.
• Targeting epigenetic pathways holds potential for novel HCC therapeutic strategies.